SMTL ID : 5vo2.1

DLK in complex with inhibitor 5-(1-isopropyl-5-(1-(oxetan-3-yl)piperidin-4-yl)-1H-pyrazol-3-yl)-3-(trifluoromethyl)pyridin-2-amine (compound 7)

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.96 Å

Oligo State

monomer

Ligands

1 x 9FV: 5-{5-[1-(oxetan-3-yl)piperidin-4-yl]-1-(propan-2-yl)-1H-pyrazol-3-yl}-3-(trifluoromethyl)pyridin-2-amine(Non-covalent)

9FV.1: 18 residues within 4Å: Chain A: V.20, G.21, S.22, G.23, Q.25, V.28, A.39, K.41, I.63, M.79, E.80, F.81, C.82, A.83, Q.84, G.85, Q.86, L.132 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:V.20, A:V.28, A:A.39, A:F.81, A:Q.86, A:L.132 Hydrogen bonds: A:E.80, A:C.82

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Patel, S. et al., Selective Inhibitors of Dual Leucine Zipper Kinase (DLK, MAP3K12) with Activity in a Model of Alzheimer's Disease. J. Med. Chem. (2017)

Release Date

2017-10-04

Peptides

Mitogen-activated protein kinase kinase kinase 12: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Mitogen-activated protein kinase kinase kinase 12

Related Entries With Identical Sequence